Wockhardt Limited (BOM:532300)
1,885.80
+55.65 (3.04%)
At close: Aug 21, 2026
Wockhardt Revenue
Wockhardt had revenue of 9.29B INR in the quarter ending June 30, 2026, with 25.88% growth. This brings the company's revenue in the last twelve months to 36.53B, up 20.40% year-over-year. In the fiscal year ending March 31, 2026, Wockhardt had annual revenue of 34.62B with 13.81% growth.
Revenue (ttm)
36.53B
Revenue Growth
+20.40%
P/S Ratio
8.39
Revenue / Employee
14.25M
Employees
2,564
Market Cap
306.51B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 34.62B | 4.20B | 13.81% |
| Mar 31, 2025 | 30.42B | 2.12B | 7.49% |
| Mar 31, 2024 | 28.30B | 1.73B | 6.51% |
| Mar 31, 2023 | 26.57B | -5.73B | -17.74% |
| Mar 31, 2022 | 32.30B | 5.22B | 19.28% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 86.08B |
| Abbott India | 70.04B |
| Granules India | 56.32B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 39.55B |
| Viyash Scientific | 35.75B |
| AstraZeneca Pharma India | 24.32B |
| Caplin Point Laboratories | 22.87B |
Wockhardt News
- 12 days ago - Wockhardt Quarterly report: Q1 2027 - Filings
- 7 weeks ago - Pharma sector stocks today, July 1: Panacea Biotec surges 4.30%, Biocon jumps 1.78%, Wockhardt up 1.66% - Business Upturn
- 2 months ago - Pharma sector stocks trade mixed on June 22: Cipla up 2.23%, Indoco Remedies gains 2.38%, Wockhardt falls 1.41% - Business Upturn
- 2 months ago - Pharma sector stocks today on June 22: Cipla up 2.23%, Indoco Remedies gains 2.38%, Wockhardt falls 1.41% - Business Upturn
- 2 months ago - Pharma sector stocks rises today, June 18: Wockhardt up 2.86%, Natco Pharma gains 2.38%, Panacea Biotech rises 2.01% - Business Upturn
- 2 months ago - Pharma sector stocks rise today, June 12: Panacea Biotech gains 2.50%, Wockhardt rises 2.24%, Natco Pharma up 1.36% - Business Upturn
- 2 months ago - Top gainers in morning trade: aegis logistics at ₹891.50 up 11.30%, wockhardt at ₹1,927.00 up 5.13%, DOMS industries at ₹2,219.90 up 4.78% - Business Upturn
- 2 months ago - Pharma sector stocks surge today, June 11: Wockhardt up 2.41%, Strides Pharma gains 2.10%, Indoco Remedies rises 2.58% - Business Upturn